• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Energy

Trending Tickers: CHK, MUR, MRO, BMY

Rising crude prices help buoy a host of oil companies Monday.
By JAMES PASSERI Aug 08, 2016 | 12:43 PM EDT
Stocks quotes in this article: CHK, MUR, MRO, BMY, MRK

U.S. markets were down slightly Monday, with the S&P 500 and Dow Jones industrials each slipping about 0.1%, despite a roughly 3% jump in crude oil prices to about $43 a barrel, based on U.S. benchmark West Texas Intermediate.

The rebound in crude prices, which were largely lifted by renewed chatter that OPEC members are again considering production cuts, helped lift shares of Chesapeake Energy (CHK) , a member of Real Money's Stressed Out watch list, to the top of the S&P 500.

Chesapeake shares were up roughly 4% in midday trading, bringing gains on the year for the Oklahoma City-based oil and gas giant to about 13%. Meanwhile, industry peers Murphy Oil (MUR) and Marathon Oil (MRO) were also up about 4% in afternoon trading.

Shares of New York pharmaceutical company Bristol-Myers Squibb (BMY) were down about 5% after unveiling that a drug in trial stages for cancer treatment had failed its most recent tests, prompting analysts at Credit Suisse to cut Bristol-Myers' rating to Neutral from Outperform.

Jefferies analysts led by Jeffrey Holford also called the disappointing results for Bristol-Myers' Checkmate-026 therapy a "major blow" for the company, and noting it could spell a short-term win for Big Pharma peer Merck (MRK) , whose shares were up about 2% in midday trading.

Shares of Ono Pharmaceutical, Bristol-Myers' Japanese partner in the development of Checkmate, also fell by as much as 20% in Japanese markets.

"While we are disappointed CheckMate-026 did not meet its primary endpoint in this broad, treatment-naïve patient population, we remain committed to improving patient outcomes through our comprehensive development program," Bristol-Myers Squibb CEO Giovanni Caforio said in a statement.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are restricted from trading individual securities.

TAGS: Investing | U.S. Equity | Healthcare | Energy | Drug Approvals | Stocks

More from Energy

An Oil Spill on Wall Street

Helene Meisler
Jul 6, 2022 6:00 AM EDT

All those bearish energy charts that I have been harping on finally fell. Let's check under the hood ... and see where the dripping is coming from.

What's the Next Move for Crude Oil?

Bruce Kamich
Jul 5, 2022 3:30 PM EDT

A temporary break in oil prices, along with lower interest rates, could be a near-term positive for equity prices.

As Oil Hits the Fan, I See a Trading Opportunity

Mark Sebastian
Jul 5, 2022 2:48 PM EDT

Let's look at how to play Devon right now.

Exxon Mobil Could See Its Shares Decline Even Further

Bruce Kamich
Jul 5, 2022 10:40 AM EDT

Let's check out the charts.

This Energy Play Should Turn Out A-'OKE'

Bret Jensen
Jul 3, 2022 7:30 AM EDT

Let's learn how to make an enhanced yield trade in Oneok.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 12:01 PM EDT PAUL PRICE

    A Recent Director Buy in Children's Place (PLCE)

    Four of the most recent insider trades in Children...
  • 07:34 AM EDT PAUL PRICE

    A $525,000 Vote of Confidence on Macerich (MAC)

  • 09:49 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    Stop Wishing, Hoping, and Praying and Take Control...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login